While developing its own proprietary technologies, Lifeline Scientific, Inc. collaborates with academic institutions and corporate partners to develop innovations aimed to advance the state of the art of organ, tissue, and cell recovery and preservation to improve outcomes in transplantation. Our development focus follows published priorities of the major US and European clinical transplant societies in three main areas: Basic Science, Translational Science (including pre-clinical models designed to advance translation of validated mechanistic discoveries to clinical applications), and Clinical Science.
For business development inquiries contact:
Business Development Department
One Pierce Place, Suite 475W
Itasca, IL 60143